TY - JOUR
T1 - Genomic investigation of multispecies and multivariant bla NDM outbreak reveals key role of horizontal plasmid transmission
AU - Dennis, Adelaide
AU - Hawkey, Jane
AU - Vezina, Ben
AU - Wisniewski, Jessica A.
AU - Cottingham, Hugh
AU - Blakeway, Luke V.
AU - Harshegyi, Taylor
AU - Pragastis, Katherine
AU - Badoordeen, Gnei Zweena
AU - Bass, Pauline
AU - Stewardson, Andrew J.
AU - Dennison, Amanda
AU - Spelman, Denis W.
AU - Jenney, Adam W.J.
A2 - Macesic, Nenad
A2 - Peleg, Anton Y.
N1 - Funding Information:
N.M. has received research support from GlaxoSmithKline, unrelated to the current study. A.Y.P. and A.J.S. have received research funding from MSD through an investigator-initiated research project. All other authors declare no conflict of interest.
Funding Information:
This work was supported by the National Health and Medical Research Council of Australia (Emerging Leader 1 Fellowship APP1176324 to N.M. and Practitioner Fellowship APP1117940 to A.Y.P). The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Publisher Copyright:
© The Author(s), 2024. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America.
PY - 2024/6
Y1 - 2024/6
N2 - Objectives: New Delhi metallo-β-lactamases (NDMs) are major contributors to the spread of carbapenem resistance globally. In Australia, NDMs were previously associated with international travel, but from 2019 we noted increasing incidence of NDM-positive clinical isolates. We investigated the clinical and genomic epidemiology of NDM carriage at a tertiary-care Australian hospital from 2016 to 2021. Methods: We identified 49 patients with 84 NDM-carrying isolates in an institutional database, and we collected clinical data from electronic medical record. Short- and long-read whole genome sequencing was performed on all isolates. Completed genome assemblies were used to assess the genetic setting of bla NDM genes and to compare NDM plasmids. Results: Of 49 patients, 38 (78%) were identified in 2019-2021 and only 11 (29%) of 38 reported prior travel, compared with 9 (82%) of 11 in 2016-2018 (P =.037). In patients with NDM infection, the crude 7-day mortality rate was 0% and the 30-day mortality rate was 14% (2 of 14 patients). NDMs were noted in 41 bacterial strains (ie, species and sequence type combinations). Across 13 plasmid groups, 4 NDM variants were detected: bla NDM-1, bla NDM-4, bla NDM-5, and bla NDM-7. We noted a change from a diverse NDM plasmid repertoire in 2016-2018 to the emergence of conserved bla NDM-1 IncN and bla NDM-7 IncX3 epidemic plasmids, with interstrain spread in 2019-2021. These plasmids were noted in 19 (50%) of 38 patients and 35 (51%) of 68 genomes in 2019-2021. Conclusions: Increased NDM case numbers were due to local circulation of 2 epidemic plasmids with extensive interstrain transfer. Our findings underscore the challenges of outbreak detection when horizontal transmission of plasmids is the primary mode of spread.
AB - Objectives: New Delhi metallo-β-lactamases (NDMs) are major contributors to the spread of carbapenem resistance globally. In Australia, NDMs were previously associated with international travel, but from 2019 we noted increasing incidence of NDM-positive clinical isolates. We investigated the clinical and genomic epidemiology of NDM carriage at a tertiary-care Australian hospital from 2016 to 2021. Methods: We identified 49 patients with 84 NDM-carrying isolates in an institutional database, and we collected clinical data from electronic medical record. Short- and long-read whole genome sequencing was performed on all isolates. Completed genome assemblies were used to assess the genetic setting of bla NDM genes and to compare NDM plasmids. Results: Of 49 patients, 38 (78%) were identified in 2019-2021 and only 11 (29%) of 38 reported prior travel, compared with 9 (82%) of 11 in 2016-2018 (P =.037). In patients with NDM infection, the crude 7-day mortality rate was 0% and the 30-day mortality rate was 14% (2 of 14 patients). NDMs were noted in 41 bacterial strains (ie, species and sequence type combinations). Across 13 plasmid groups, 4 NDM variants were detected: bla NDM-1, bla NDM-4, bla NDM-5, and bla NDM-7. We noted a change from a diverse NDM plasmid repertoire in 2016-2018 to the emergence of conserved bla NDM-1 IncN and bla NDM-7 IncX3 epidemic plasmids, with interstrain spread in 2019-2021. These plasmids were noted in 19 (50%) of 38 patients and 35 (51%) of 68 genomes in 2019-2021. Conclusions: Increased NDM case numbers were due to local circulation of 2 epidemic plasmids with extensive interstrain transfer. Our findings underscore the challenges of outbreak detection when horizontal transmission of plasmids is the primary mode of spread.
UR - http://www.scopus.com/inward/record.url?scp=85187276417&partnerID=8YFLogxK
U2 - 10.1017/ice.2024.8
DO - 10.1017/ice.2024.8
M3 - Article
C2 - 38344902
AN - SCOPUS:85187276417
SN - 0899-823X
VL - 45
SP - 709
EP - 716
JO - Infection Control & Hospital Epidemiology
JF - Infection Control & Hospital Epidemiology
IS - 6
ER -